John K. Scott Jr., 10% Owner at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), bought 5,000 shares at $5.00 ($25K) on 2020-08-30, disclosed to the SEC on 2020-09-02.
Open-market purchase of $25k NAVB by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| NAVB | BUY | 2019-06-21 | $3.0M | — | Filing → |
| NAVB | BUY | 2019-03-25 | $100K | — | Filing → |